CD103+ Tumor-Resident CD8+ T Cells Are Associated with Improved Survival in Immunotherapy-Naïve Melanoma Patients and Expand Significantly During Anti-PD-1 Treatment

Edwards, J., Wilmott, J. S., Madore, J., Gide, T. N., Quek, C., Tasker, A., Ferguson, A., Chen, J., Hewavisenti, R., Hersey, P., Gebhardt, T., Weninger, W., Britton, W. J., Saw, R. P. M., Thompson, J. F., Menzies, A. M., Long, G. V., Scolyer, R. A., Palendira, U.
The American Association for Cancer Research (AACR)
Published 2018